ODPM Onco Drug Personalized Medicine
www.odpm.frFounded in 2010, ODPM creates, develops and markets innovative and high performance solutions for personalized medicine in oncology. Its services are emanations of the team work and the research studies of the Oncopharmacology Laboratory at the Cancerology Institute of the West (ICO) Paul Papin and Angers University in Angers, France. The company offers two complementary ranges of products: > ODPM Tox™ to prevent severe toxic side effects through a combined genetic and phenotyping approach; > ODPM Protocol™ to optimize treatment efficiency by adapting dosage to each patient.
Read moreFounded in 2010, ODPM creates, develops and markets innovative and high performance solutions for personalized medicine in oncology. Its services are emanations of the team work and the research studies of the Oncopharmacology Laboratory at the Cancerology Institute of the West (ICO) Paul Papin and Angers University in Angers, France. The company offers two complementary ranges of products: > ODPM Tox™ to prevent severe toxic side effects through a combined genetic and phenotyping approach; > ODPM Protocol™ to optimize treatment efficiency by adapting dosage to each patient.
Read moreCountry
City (Headquarters)
Angers
Industry
Employees
1-10
Founded
2010
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Manager - Co - Founder
Email ****** @****.comPhone (***) ****-****Director , International Marketing and Operations
Email ****** @****.comPhone (***) ****-****Research and Development Consultant
Email ****** @****.comPhone (***) ****-****
Technologies
(3)